ADMA BIOLOGICS, INC.

Annual Trend FY 2016 FY 2017 FY 2018 FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025
ASSETS
Current assets:
Cash and Cash Equivalents, at Carrying Value $9.9m $43.1m $22.8m $26.8m $55.9m $51.1m $86.5m $51.4m $103.1m $87.6m
Prepaid Expense and Other Assets, Current $314k $2.1m $1.8m $2.5m $3.0m $4.3m $5.1m $5.3m $8.0m $7.5m
Short-term Investments $5.4m $0
Inventory, Net $5.0m $12.6m $18.6m $53.1m $81.5m $124.7m $163.3m $172.9m $170.2m $206.5m
Assets, Current $21.7m $63.2m $44.5m $85.8m $153.7m $208.7m $270.4m $257.0m $331.4m $466.5m
Property, Plant and Equipment, Net $2.0m $30.5m $30.1m $31.7m $41.6m $50.9m $58.3m $53.8m $54.7m $65.1m
Goodwill $0 $3.5m $3.5m $3.5m $3.5m $3.5m $3.5m $3.5m $3.5m $3.5m
Intangible Assets, Net (Excluding Goodwill) $4.8m $4.0m $3.2m $2.4m $1.7m $1.0m $499k $460k $632k
Operating Lease, Right-of-Use Asset $4.3m $7.3m $10.5m $9.6m $8.6m $6.7m
Additional Financial Items
Accounts Receivable, after Allowance for Credit Loss, Current $1.0m $3.9m $1.4m $3.5m $13.2m $28.6m $15.5m $27.4m $50.0m $158.4m
Accrued Liabilities, Current $2.4m $3.3m $3.6m $4.5m $8.4m $17.2m $25.0m $32.9m $34.0m $40.5m
Assets $23.7m $108.0m $88.9m $127.1m $207.7m $276.3m $348.5m $329.2m $488.7m $624.2m
LIABILITIES AND EQUITY
Current liabilities:
Operating Lease, Liability, Current $229k $366k $591k $905k $1.0m $1.2m $1.1m
Accounts Payable, Current $2.6m $5.9m $5.9m $9.2m $11.1m $12.4m $13.2m $15.7m $20.2m $22.5m
Operating Lease, Liability, Noncurrent $7.5m $10.7m $9.8m $8.6m $6.6m
Deferred Revenue, Current $2.7m $143k $143k $143k $143k $2.0m $1.8m $1.7m $1.5m $1.4m
Deferred Revenue, Noncurrent $2.7m $2.5m $2.4m $2.3m $2.1m $2.0m $1.8m $1.7m $1.5m $1.4m
Long-term Debt, Excluding Current Maturities $20k $2.8m $2.8m $0 $93.0m $72.3m $69.3m
Long-term Debt, Current Maturities $0 $2.8m
Liabilities, Current $11.2m $9.4m $9.6m $14.0m $19.9m $30.4m $39.3m $49.8m $55.5m $69.5m
Other Liabilities, Noncurrent $1.8m $106k $261k $107k $55k $397k $350k $419k $360k $0
Liabilities $28.1m $67.7m $69.1m $100.9m $119.4m $135.1m $196.5m $194.0m $139.7m $146.9m
Commitments and Contingencies $0 $0
Stockholders’ equity:
Preferred Stock, Value, Issued $0 $0 $0 $0 $0 $0 $0 $0 $0 $0
Common Stock, Value, Issued $1k $4k $5k $6k $10k $20k $22k $23k $24k $24k
Additional Paid in Capital $102.5m $191.0m $236.2m $290.9m $428.7m $553.3m $630.0m $641.4m $657.6m $671.0m
Retained Earnings (Accumulated Deficit) ($106.9m) ($150.7m) ($216.4m) ($264.7m) ($340.5m) ($412.1m) ($478.0m) ($506.3m) ($308.6m) ($161.7m)
Stockholders' Equity Attributable to Parent ($4.5m) $40.3m $19.8m $26.2m $88.2m $141.2m $152.0m $135.2m $349.0m $477.3m
Liabilities and Equity $23.7m $108.0m $88.9m $127.1m $207.7m $276.3m $348.5m $329.2m $488.7m $624.2m